TRIBUNE THERAPEUTICS
HQ - Stockholm
Summary
Tribune Therapeutics is a operator of a preclinical biopharmaceutical company focused on building novel medicines to treat patients with a wide range of fibrotic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 31 M
Avg. Deal Size£ 31 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
